SK54694A3 - Subcutaneous implantants derivatives nomegestrol based - Google Patents

Subcutaneous implantants derivatives nomegestrol based Download PDF

Info

Publication number
SK54694A3
SK54694A3 SK546-94A SK54694A SK54694A3 SK 54694 A3 SK54694 A3 SK 54694A3 SK 54694 A SK54694 A SK 54694A SK 54694 A3 SK54694 A3 SK 54694A3
Authority
SK
Slovakia
Prior art keywords
norpregna
methyl
composition according
implant
diene
Prior art date
Application number
SK546-94A
Other languages
English (en)
Slovak (sk)
Inventor
Michel Lanquetin
Jean Louis Thomas
Jacques Paris
Elsimar Coutinho
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of SK54694A3 publication Critical patent/SK54694A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK546-94A 1992-09-21 1993-09-17 Subcutaneous implantants derivatives nomegestrol based SK54694A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9211422A FR2695826B1 (fr) 1992-09-21 1992-09-21 Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
PCT/FR1993/000900 WO1994006437A1 (fr) 1992-09-21 1993-09-17 Implants sous-cutanes a base de derives de nomegestrol

Publications (1)

Publication Number Publication Date
SK54694A3 true SK54694A3 (en) 1994-10-05

Family

ID=9433868

Family Applications (1)

Application Number Title Priority Date Filing Date
SK546-94A SK54694A3 (en) 1992-09-21 1993-09-17 Subcutaneous implantants derivatives nomegestrol based

Country Status (31)

Country Link
US (1) US5565443A (ru)
EP (1) EP0613372B1 (ru)
JP (1) JPH08506318A (ru)
KR (1) KR100255700B1 (ru)
CN (1) CN1095667C (ru)
AP (1) AP497A (ru)
AT (1) ATE198275T1 (ru)
AU (1) AU683423B2 (ru)
BG (1) BG62317B1 (ru)
BR (1) BR9305642A (ru)
CA (1) CA2122827A1 (ru)
CZ (1) CZ284806B6 (ru)
DE (1) DE69329790D1 (ru)
DZ (1) DZ1717A1 (ru)
EC (1) ECSP930986A (ru)
FI (1) FI942272A0 (ru)
FR (1) FR2695826B1 (ru)
HU (1) HUT67044A (ru)
IL (1) IL107039A (ru)
MA (1) MA22978A1 (ru)
NO (1) NO306238B1 (ru)
OA (1) OA09924A (ru)
PL (1) PL176120B1 (ru)
RO (1) RO115783B1 (ru)
RU (1) RU2120797C1 (ru)
SK (1) SK54694A3 (ru)
TN (1) TNSN93104A1 (ru)
TW (1) TW381024B (ru)
WO (1) WO1994006437A1 (ru)
YU (1) YU60493A (ru)
ZA (1) ZA936964B (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
CA2452412C (en) 2001-06-29 2011-05-24 Medgraft Microtech, Inc. Biodegradable injectable implants and related methods of manufacture and use
PT2561860T (pt) * 2002-05-31 2018-05-08 Titan Pharmaceuticals Inc Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
EP1610791B1 (en) * 2003-03-31 2011-02-23 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of dopamine agonist
MXPA05012768A (es) * 2003-05-30 2006-02-22 Titan Pharmaceuticals Inc Dispositivo polimerico implantable para liberacion prolongada de nalmefeno.
JP5619337B2 (ja) 2003-10-10 2014-11-05 フェリング ビー.ブイ. 皮膚残渣を最小限に抑えるための経皮的医薬製剤
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US8067399B2 (en) 2005-05-27 2011-11-29 Antares Pharma Ipl Ag Method and apparatus for transdermal or transmucosal application of testosterone
CN101426475A (zh) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147783A (en) * 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4172132A (en) * 1977-07-26 1979-10-23 Schering Corporation 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
US5223492A (en) * 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them
FR2664895B1 (fr) * 1990-07-20 1992-10-30 Theramex Laboratoire Nouveaux derives de la 6-methyl 19-nor progesterone, substitues en 3 et leur procede d'obtention.

Also Published As

Publication number Publication date
EP0613372B1 (fr) 2000-12-27
BR9305642A (pt) 1996-01-09
FI942272A (fi) 1994-05-16
PL176120B1 (pl) 1999-04-30
IL107039A (en) 1999-01-26
FR2695826B1 (fr) 1995-01-06
HUT67044A (en) 1995-01-30
TNSN93104A1 (fr) 1994-03-17
BG98776A (bg) 1995-02-28
JPH08506318A (ja) 1996-07-09
NO941900L (no) 1994-05-24
CN1094284A (zh) 1994-11-02
MA22978A1 (fr) 1994-04-01
ATE198275T1 (de) 2001-01-15
TW381024B (en) 2000-02-01
CZ116494A3 (en) 1995-03-15
US5565443A (en) 1996-10-15
CN1095667C (zh) 2002-12-11
HU9401395D0 (en) 1994-08-29
AU4822993A (en) 1994-04-12
AU683423B2 (en) 1997-11-13
WO1994006437A1 (fr) 1994-03-31
EP0613372A1 (fr) 1994-09-07
KR100255700B1 (ko) 2000-08-01
AP9300576A0 (ru) 1993-10-31
AP497A (en) 1996-05-28
ZA936964B (en) 1994-04-14
CA2122827A1 (fr) 1994-03-31
DE69329790D1 (de) 2001-02-01
NO306238B1 (no) 1999-10-11
CZ284806B6 (cs) 1999-03-17
RU2120797C1 (ru) 1998-10-27
NO941900D0 (no) 1994-05-20
BG62317B1 (bg) 1999-08-31
ECSP930986A (es) 1994-04-12
YU60493A (sh) 1997-01-08
IL107039A0 (en) 1993-12-28
FR2695826A1 (fr) 1994-03-25
OA09924A (fr) 1994-09-15
RO115783B1 (ro) 2000-06-30
FI942272A0 (fi) 1994-05-16
DZ1717A1 (fr) 2002-02-17

Similar Documents

Publication Publication Date Title
SK54694A3 (en) Subcutaneous implantants derivatives nomegestrol based
US5855906A (en) Intravaginal drug delivery devices for the administration of 17β-oestradiol precursors
US5660848A (en) Subdermally implantable device
DK2905014T3 (en) An intrauterine delivery system for contraception
US6416780B1 (en) Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
EP1488784B1 (en) Male contraceptive implant
EA018112B1 (ru) Вагинальная система доставки
CN1073422C (zh) 抗孕激素在制备减少子宫出血的药物中的应用
CA2927750A1 (en) Intrauterine delivery system
Sam Controlled release contraceptive devices: a status report
EP2062569B1 (en) Vaginal delivery system
AU747710B2 (en) Progestogen-antiprogestogen regimens
Lishko et al. WITHDRAWN APPLICATION AS PER THE LATEST USPTO WITHDRAWN LIST
Sondheimer Cervical mucus and contraception
IES950959A2 (en) Intravaginal drug delivery devices for the administration of 17ß-oestradiol precursors